Search Results 1271-1280 of 16972 for monoclonal antibody
Use of targeted agents (e.g., monoclonal antibodies or kinase inhibitors) will not be counted as a prior chemotherapy treatment; Patients with known EGFR ...
Daratumumab is a human immunoglobulin G1κ monoclonal antibody that binds CD38, and has been demonstrated to be safe and effective in patients with ...
Monoclonal antibodies: > 21 days must have elapsed from the infusion of last dose of antibody and toxicity related to antibody therapy must be recovered to ...
... monoclonal antibody (e.g., rituximab) in combination with chemotherapy. Measurable disease as defined below: Fluorodeoxyglucose (FDG)-avid lymphomas ...
The purpose of this study is to assess antibody activity IN vitro in cold agglutinin disease (CAD) patients. Participation eligibility. Participant ...
Known severe hypersensitivity reactions to monoclonal antibodies (Grade ≥ 3 NCI-CTC V4.03 or V5.0 for phase II part 2), any history of anaphylaxis, or ...
Monoclonal antibody drugs · Mort Crim and Cancer · Mouth sores caused by cancer treatment: How to cope · MRI · Muscle pain · Needle biopsy · Night sweats · No ...
To describe the demographics and comorbidities of patients with false positive testing for HIV-1 and HIV 2 (defined as positive or indeterminate antibody ...
Routine IHC/IF. Automated immunostaining is performed using a variety of antibody detection chemistries, including diaminobenzidine (DAB) and alkaline ...
Chemotherapy, immunotherapy, hormonal therapy, and monoclonal antibodies (but excluding nitrosourea, mitomycin-C, targeted therapy) ≤ 28 days prior to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.